Skip to content
DataLookout
Menu

KATD-PAINNCT07064993

Effects of Intraarticular Tramadol and Tramadol-Dexamethasone on Postoperative Pain After Knee Arthroscopy

StatusActive, Not Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Start date changed from estimate of Jul 15, 2026 to Jun 15, 2025
  2. Notable Start date: May 29, 2026 to Jul 15, 2026v4 Show 4 more changesShow less
    • Primary endpoint(s) modified
    • Eligibility criteria shortened, about 3 words
    • Secondary endpoints revised (7)
    • Study description expanded, about 67 words
  3. Notable Phase: Not applicable to Phase 4v3 Show 13 more changesShow less
    • Lead sponsor: Yuzuncu Yil University to Arzu Esen Tekeli
    • Enrollment target: 80 to 135
    • Primary completion date: Aug 2, 2026 to Feb 26, 2027
    • Start date: Sep 2, 2025 to May 29, 2026
    • Eligibility criteria expanded, about 48 words
    • Primary endpoint revised
    • Trial status: Active, Not Recruiting to Not Yet Recruiting
    • Study completion date: Sep 2, 2026 to Apr 30, 2027
    • Interventions: Experimental (Procedure), Observation (Other) to Saline (Drug), Tramadol (Drug), Tramadol + Dexamethasone (Drug)
    • Secondary endpoints: 1 to 7
    • Study description expanded, about 154 words
    • Study arms: 2 to 3
    • Study title shortened, about 3 words
  4. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Postoperative pain intensity - Area Under the Curve (VAS AUC 0-24 hours)
Timeframe: 0, 2, 6, 12, 24 hours postoperatively

Secondary (7)

Time to first analgesic requirement
Total analgesic consumption
Postoperative nausea severity (0-3 scale)
Number of vomiting episodes
Postoperative itching severity (0-3 scale)
Show 2 moreShow less
Postoperative shivering severity (0-3 scale)
Adverse events

Arms and interventions

Placebo GroupPlacebo comparator

Patients will receive 20 mL of normal saline administered intraarticularly at the end of surgery.

Tramadol GroupExperimental

Patients will receive 100 mg tramadol diluted with saline to a total volume of 20 mL, administered intraarticularly at the end of surgery.

Tramadol + Dexamethasone GroupExperimental

Patients will receive 100 mg tramadol combined with 8 mg dexamethasone diluted with saline to a total volume of 20 mL, administered intraarticularly at the end of surgery.

Drugs: Saline, Tramadol, Tramadol + Dexamethasone

Sites

1 site in 1 country

  • Van Yuzuncu Yil University School of Medicine Department of Anesthesiology and ReanimationVan, Turkey (Türkiye)